Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background.

Nayak S. et al, (2024), Nat Commun, 15

Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.

Miotto O. et al, (2024), Lancet Microbe

Towards integrated malaria molecular surveillance in Africa.

Dada N. et al, (2024), Trends Parasitol

Genetic surveillance ofPlasmodium falciparumreveals rapid population changes following first-line treatment policy revisions in the Greater Mekong Subregion

Verschuuren TD. et al, (2024)

Molecular markers of artemisinin resistance during falciparum malaria elimination in Eastern Myanmar.

Thu AM. et al, (2024), Malar J, 23

Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis.

Wasakul V. et al, (2023), Lancet Infect Dis, 23, 568 - 577

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

MalariaGEN None. et al, (2023), Wellcome Open Res, 8

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.

MalariaGEN None. et al, (2023), Wellcome open research, 8

Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite Plasmodium falciparum.

Kucharski M. et al, (2023), PLoS Pathog, 19

A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.

Trimarsanto H. et al, (2022), Commun Biol, 5

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.

Peto TJ. et al, (2022), Lancet Infect Dis, 22, 867 - 878

DiMA: Sequence Diversity Dynamics Analyser for Viruses

Tharanga S. et al, (2022)

An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.

MalariaGEN None. et al, (2022), Wellcome Open Res, 7

Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.

Coulibaly A. et al, (2022), Front Genet, 13

Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion.

Imwong M. et al, (2021), Antimicrob Agents Chemother, 65

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.

Hamaluba M. et al, (2021), Lancet Infect Dis, 21, 1395 - 1406

Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination.

Jacob CG. et al, (2021), Elife, 10

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response.

Zhu L. et al, (2021)

The mechanism of artemisinin resistance of Plasmodium falciparum malaria parasites originates in their initial transcriptional response

Zhu L. et al, (2021)

Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea.

Miotto O. et al, (2020), PLoS Pathog, 16

Load More

Include forthcoming?